Sarah Ford | December 12, 2013
New York Times Puts the Spotlight on Progress in Marfan Research
In the 1970s, the life expectancy for someone with Marfan syndrome was in the 40s. Less than thirty years later, due to early diagnosis, new medications, and advances in surgery, the life expectancy for people with Marfan syndrome was in the 70s, nearing the life expectancy of the general population.
In the past decade, research has accelerated even faster, giving our community real hope for a medication that may prevent aortic enlargement, the life-threatening part of Marfan syndrome, and a potential blood test that could predict who is at risk for aortic problems. The December 3 issue of the New York Times put the focus on these recent research breakthroughs that offer our community hope.
Source: The Marfan Foundation
Get Resources and Insights Straight To Your Inbox
Explore More Articles
International Self Care Day
Today, July 24, 2025, we celebrate International Self Care Day, a day dedicated to promoting self-care practices and their numerous benefits for physical, mental, and…
Read ArticleHow the “Big Beautiful Bill” Will Impact Individual Giving and Employer-Sponsored Workplace Giving Programs
The One Big Beautiful Bill was signed into law on July 4, 2025, introducing a range of provisions that will affect how individuals, companies, and…
Read ArticleGet Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.